Posted by Michael Wonder on 01 Aug 2024
First targeted treatment made available for hundreds of blood cancer patients on the NHS
1 August 2024 - A take at home tablet which could be a ‘game-changer’ for hundreds of blood cancer patients is now available on the NHS in England.
Patients in England with a form of blood cancer known as marginal zone lymphoma can now be offered an additional treatment option which could halt the progression of their cancer and provide an alternative to further rounds of chemotherapy.
Zanubrutinib is the first ever treatment specifically licensed for this form of blood cancer, recommended by NICE\ for use on the NHS today.
